Browsing Artículos by Author "Bechmann, Lars P."

Now showing items 1-2 of 2

    • Thumbnail

      Anti-TNFα treatment in Crohn’s disease: Impact on hepatic steatosis, gut-derived hormones and metabolic status 

      Manka, Paul; Sydor, Svenja; Wase, Nishikant; Best, Jan; Brandenburg, Malte; Hellbeck, Annika; Schänzer, Julia; Vilchez-Vargas, Ramiro; Link, Alexander; Figge, Anja; Jähnert, Andreas; Von Arnim, Ulrike; Coombes, Jason D.; Cubero, Francisco-Javier; Kahraman, Alisan; Kim, Moon-Sung; Kälsch, Julia; Kinner, Sonja; Faber, Klaas-Nico; Moshage, Han; Gerken, Guido; Syn, Wing-Kin; Friedman, Scott L.; Canbay, Ali; Bechmann, Lars P. (Wiley, 2021-11)
      Background and Aims An association between Crohn's disease (CD) and hepatic steatosis has been reported. However, the underlying mechanisms of steatosis progression in CD are not clear. Among the most effective CD treatments ...
    • Thumbnail

      Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD) 

      Estévez-Vázquez, Olga; Benedé-Ubieto, Raquel; Guo, Feifei; Gómez Santos, Beatriz; Aspichueta Celaá, Patricia; Reissing, Johanna; Bruns, Tony; Sanz-García, Carlos; Sydor, Svenja; Bechmann, Lars P.; Maranillo, Eva; Sañudo, José Ramón; Vázquez, María Teresa; Lamas-Paz, Arantza; Morán, Laura; Mazariegos, Marina S.; Ciudin, Andreea; Pericàs, Juan M.; Peligros, María Isabel; Vaquero, Javier; Martínez-Naves, Eduardo; Liedtke, Christian; Regueiro, José R.; Trautwein, Christian; Bañares, Rafael; Cubero, Francisco Javier; Nevzorova, Yulia A. (MDPI, 2021-09-22)
      Objectives: Lately, many countries have restricted or even banned transfat, and palm oil has become a preferred replacement for food manufacturers. Whether palm oil is potentially an unhealthy food mainly due to its high ...